SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals ... 4-traders The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect of a targeted biologic monoclonal antibody augmented with the therapeutic effects of a ... Spectrum Pharmaceuticals Announces Publication in the Journal of Clinical ... |
